Yang et al. determined an ROC curve in 46 ER+ BC patients, showing an optimal SUVmax cutoff of 1.8, with a sensitivity of 88% and specificity of 88% (optimal SUVmean cutoff: 1.2) [79]. This evidence concerns the gene ESR1 and breast cancer.